Sinobiopharma Inc.’s (SNBP.OB) Flagship Product Covered by China’s Basic Medical Insurance

In the company’s news yesterday,

Sinobiopharma Inc. announced today that the Chinese government has approved the company’s flagship product Ku Tai (Cisatracurium Besylate) for coverage under National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance. Sinobiopharma’s flagship product, which has been on the market since 2006, had not been covered by any medical insurance before the Chinese government granted approval for its inclusion on the list of insured drugs on November 27, 2009.

Before coverage was approved, patients who chose Ku Tai – a skeletal muscle relaxant used for surgery and used in more than 1,000 hospitals located in almost every province, did so at their own expense. National Basic Medical Insurance will now provide for patients to be reimbursed for any use of Ku Tai. This insurance is part of China’s major healthcare reform plan. Under this plan, more than 90 percent of its urban population of 600 million will be covered by National Basic Medical Insurance by the end of 2010.

Similar drugs from Sinobiopharma’s competitors were already covered by insurance. But even with this competitive disadvantage, Ku Tai still managed to gain significant market share because of its greater efficacy and superior safety profile. The company expects Ku Tai’s inclusion on the list of insured drugs will drive a significant increase in Ku Tai’s sales volume and further gains in market share.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.